Detalus Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Detalus Advisors's LLY Position: Q3 2026 in Review
Detalus Advisors increased its Eli Lilly (LLY) stake by 4% in Q3 2026, buying an estimated $41.3K and bringing the position to 907 shares worth $1.05M. The position accounts for 0.21% of the portfolio, ranked #60.
Detalus Advisors first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 1,011 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Detalus Advisors held 907 shares of Eli Lilly worth $1.05M as of Q3 2026.
- Detalus Advisors bought 35 Eli Lilly shares in Q3 2026, an estimated $41.3K.
- Eli Lilly made up 0.21% of Detalus Advisors's portfolio in Q3 2026, its #60 holding.
- Detalus Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- 1,011 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Detalus Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.